Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist recently approved for Type 2 diabetes and increasingly recognized for weight management. Its dual-action mechanism allows for more significant weight loss than traditional GLP-1 treatments like Ozempic or Saxenda.
1️⃣ How Mounjaro Works
Mounjaro activates two hormones:
- GLP-1: Increases insulin, suppresses glucagon, slows gastric emptying, reduces appetite
- GIP: Enhances insulin release and promotes fat metabolism
The combination leads to greater weight loss and improved glycemic control compared to single-target GLP-1 treatments.
2️⃣ Dosing Schedule
Mounjaro is administered once weekly via injection. The typical titration schedule:
| Week | Dose |
|---|---|
| 1–4 | 2.5 mg |
| 5–8 | 5 mg |
| 9–12 | 7.5 mg |
| 13–16 | 10 mg |
| 17–20 | 12.5 mg |
| 21+ | 15 mg (maintenance) |
⚠️ Always follow your healthcare provider’s guidance for dose escalation.
3️⃣ Expected Weight Loss
Clinical trials (SURPASS) show:
- 12–20% body weight reduction over 40–68 weeks
- Improvements in waist circumference, BMI, and metabolic markers
- Benefits are dose-dependent, with higher doses yielding greater results
4️⃣ Mounjaro for weight loss Side Effects
Most side effects are mild and temporary, usually during dose escalation:
- Nausea, vomiting, diarrhea, constipation
- Reduced appetite
- Mild fatigue or abdominal discomfort
Tip: Starting at 2.5 mg helps minimize GI symptoms.
5️⃣ Tips for Success
- Follow titration schedule carefully
- Combine therapy with healthy diet and exercise
- Track weight and progress weekly
- Communicate with your healthcare provider if side effects persist
6️⃣ Key Takeaways
- Mounjaro is a powerful GLP-1/GIP dual agonist for weight loss and diabetes control
- Expect gradual, dose-dependent weight reduction
- Proper titration, lifestyle changes, and medical supervision are essential for optimal results